NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls

Abstract Niemann-Pick type C1 (NPC1) disease is a rare autosomal recessive, neurodegenerative lysosomal storage disorder, which presents with a range of clinical phenotypes and hence diagnosis remains a challenge. In view of these difficulties, the search for a novel, NPC1-specific biomarker (or set...

Full description

Bibliographic Details
Main Authors: Fay Probert, Victor Ruiz-Rodado, Danielle te Vruchte, Elena-Raluca Nicoli, Tim D. W. Claridge, Christopher A. Wassif, Nicole Farhat, Forbes D. Porter, Frances M. Platt, Martin Grootveld
Format: Article
Language:English
Published: Nature Portfolio 2017-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-06264-2
_version_ 1818754243715137536
author Fay Probert
Victor Ruiz-Rodado
Danielle te Vruchte
Elena-Raluca Nicoli
Tim D. W. Claridge
Christopher A. Wassif
Nicole Farhat
Forbes D. Porter
Frances M. Platt
Martin Grootveld
author_facet Fay Probert
Victor Ruiz-Rodado
Danielle te Vruchte
Elena-Raluca Nicoli
Tim D. W. Claridge
Christopher A. Wassif
Nicole Farhat
Forbes D. Porter
Frances M. Platt
Martin Grootveld
author_sort Fay Probert
collection DOAJ
description Abstract Niemann-Pick type C1 (NPC1) disease is a rare autosomal recessive, neurodegenerative lysosomal storage disorder, which presents with a range of clinical phenotypes and hence diagnosis remains a challenge. In view of these difficulties, the search for a novel, NPC1-specific biomarker (or set of biomarkers) is a topic of much interest. Here we employed high-resolution 1H nuclear magnetic resonance spectroscopy coupled with advanced multivariate analysis techniques in order to explore and seek differences between blood plasma samples acquired from NPC1 (untreated and miglustat treated), heterozygote, and healthy control subjects. Using this approach, we were able to identify NPC1 disease with 91% accuracy confirming that there are significant differences in the NMR plasma metabolic profiles of NPC1 patients when compared to healthy controls. The discrimination between NPC1 (both miglustat treated and untreated) and healthy controls was dominated by lipoprotein triacylglycerol 1H NMR resonances and isoleucine. Heterozygote plasma samples displayed also increases in the intensities of selected lipoprotein triacylglycerol 1H NMR signals over those of healthy controls. The metabolites identified could represent useful biomarkers in the future and provide valuable insight in to the underlying pathology of NPC1 disease.
first_indexed 2024-12-18T05:20:10Z
format Article
id doaj.art-486e2509b932488d83bb2463ee51ff9c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T05:20:10Z
publishDate 2017-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-486e2509b932488d83bb2463ee51ff9c2022-12-21T21:19:40ZengNature PortfolioScientific Reports2045-23222017-07-017111210.1038/s41598-017-06264-2NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controlsFay Probert0Victor Ruiz-Rodado1Danielle te Vruchte2Elena-Raluca Nicoli3Tim D. W. Claridge4Christopher A. Wassif5Nicole Farhat6Forbes D. Porter7Frances M. Platt8Martin Grootveld9Department of Pharmacology, De Montfort UniversityDepartment of Pharmacology, De Montfort UniversityDepartment of Pharmacology, University of OxfordDepartment of Pharmacology, University of OxfordDepartment of Chemistry, University of OxfordDepartment of Pharmacology, University of OxfordSection of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Department of Health and Human ServicesSection of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Department of Health and Human ServicesDepartment of Pharmacology, University of OxfordDepartment of Pharmacology, De Montfort UniversityAbstract Niemann-Pick type C1 (NPC1) disease is a rare autosomal recessive, neurodegenerative lysosomal storage disorder, which presents with a range of clinical phenotypes and hence diagnosis remains a challenge. In view of these difficulties, the search for a novel, NPC1-specific biomarker (or set of biomarkers) is a topic of much interest. Here we employed high-resolution 1H nuclear magnetic resonance spectroscopy coupled with advanced multivariate analysis techniques in order to explore and seek differences between blood plasma samples acquired from NPC1 (untreated and miglustat treated), heterozygote, and healthy control subjects. Using this approach, we were able to identify NPC1 disease with 91% accuracy confirming that there are significant differences in the NMR plasma metabolic profiles of NPC1 patients when compared to healthy controls. The discrimination between NPC1 (both miglustat treated and untreated) and healthy controls was dominated by lipoprotein triacylglycerol 1H NMR resonances and isoleucine. Heterozygote plasma samples displayed also increases in the intensities of selected lipoprotein triacylglycerol 1H NMR signals over those of healthy controls. The metabolites identified could represent useful biomarkers in the future and provide valuable insight in to the underlying pathology of NPC1 disease.https://doi.org/10.1038/s41598-017-06264-2
spellingShingle Fay Probert
Victor Ruiz-Rodado
Danielle te Vruchte
Elena-Raluca Nicoli
Tim D. W. Claridge
Christopher A. Wassif
Nicole Farhat
Forbes D. Porter
Frances M. Platt
Martin Grootveld
NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
Scientific Reports
title NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
title_full NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
title_fullStr NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
title_full_unstemmed NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
title_short NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
title_sort nmr analysis reveals significant differences in the plasma metabolic profiles of niemann pick c1 patients heterozygous carriers and healthy controls
url https://doi.org/10.1038/s41598-017-06264-2
work_keys_str_mv AT fayprobert nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT victorruizrodado nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT danielletevruchte nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT elenaralucanicoli nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT timdwclaridge nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT christopherawassif nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT nicolefarhat nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT forbesdporter nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT francesmplatt nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols
AT martingrootveld nmranalysisrevealssignificantdifferencesintheplasmametabolicprofilesofniemannpickc1patientsheterozygouscarriersandhealthycontrols